Amphastar Pharmaceuticals Inc
NASDAQ:AMPH

Watchlist Manager
Amphastar Pharmaceuticals Inc Logo
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Watchlist
Price: 45.06 USD -0.92% Market Closed
Market Cap: 2.2B USD
Have any thoughts about
Amphastar Pharmaceuticals Inc?
Write Note

Amphastar Pharmaceuticals Inc
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Amphastar Pharmaceuticals Inc
Total Receivables Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Total Receivables
$132.1m
CAGR 3-Years
24%
CAGR 5-Years
22%
CAGR 10-Years
19%
Johnson & Johnson
NYSE:JNJ
Total Receivables
$16.2B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Total Receivables
$14.9B
CAGR 3-Years
8%
CAGR 5-Years
23%
CAGR 10-Years
17%
Pfizer Inc
NYSE:PFE
Total Receivables
$15.1B
CAGR 3-Years
8%
CAGR 5-Years
10%
CAGR 10-Years
4%
Merck & Co Inc
NYSE:MRK
Total Receivables
$12.2B
CAGR 3-Years
12%
CAGR 5-Years
8%
CAGR 10-Years
6%
Eli Lilly and Co
NYSE:LLY
Total Receivables
$12.1B
CAGR 3-Years
20%
CAGR 5-Years
17%
CAGR 10-Years
13%

See Also

What is Amphastar Pharmaceuticals Inc's Total Receivables?
Total Receivables
132.1m USD

Based on the financial report for Jun 30, 2024, Amphastar Pharmaceuticals Inc's Total Receivables amounts to 132.1m USD.

What is Amphastar Pharmaceuticals Inc's Total Receivables growth rate?
Total Receivables CAGR 10Y
19%

Over the last year, the Total Receivables growth was 25%. The average annual Total Receivables growth rates for Amphastar Pharmaceuticals Inc have been 24% over the past three years , 22% over the past five years , and 19% over the past ten years .

Back to Top